# Twist Bioscience Corporation (TWST) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TWST
## Company Profile
- Ticker: TWST
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 128.06 USD
- Market cap: 4368332677.1 USD
- Last updated: 2026-09-08
## Business Overview
### Synthetic Biology Platform
Twist Bioscience manufactures customizable synthetic DNA and related biological products at scale. Its platform is designed to improve the speed, throughput and precision of research and development workflows.
### Oligos and Genes
Core products include oligonucleotides, genes and complex DNA constructs used by researchers to build, test and optimize biological designs across large experimental programs.
### Next-Generation Sequencing
Twist supplies target-enrichment panels and workflow tools for next-generation sequencing in research, diagnostics and translational medicine.
### Biopharma Solutions
The company provides antibody-discovery libraries, protein products and characterization data that help biotechnology and pharmaceutical customers identify and optimize therapeutic candidates.
### Broad End Markets
Twist serves customers in therapeutics, diagnostics, industrial biotechnology, agriculture and academic research, applying the same manufacturing platform across diverse biological applications.
## Why The Stock Is Moving

The latest monitored company update is “Twist Bioscience to Present at Baird 2026 Global Healthcare Conference.” The corresponding closing-price reaction is not yet available.

## Recent News
- 2026-09-09 12:00 EST — [Twist Bioscience to Present at Baird 2026 Global Healthcare Conference](https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-baird-2026-global-healthcare-conference-e396b989) — Source: Twist Bioscience Corporation
- 2026-08-05 03:45 EST — [Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-pricing-of-upsized-300-0-million-public-offering-of-c-0c189948) — Source: Twist Bioscience Corporation
- 2026-08-04 20:01 EST — [Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-proposed-public-offering-of-250-0-million-of-common-s-242d974e) — Source: Twist Bioscience Corporation
- 2026-08-04 12:00 EST — [Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/TWST/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-ru-6b7d2061) — Source: Twist Bioscience Corporation
- 2026-08-03 11:15 EST — [Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-third-quarter-financial-results-a79ae39a) — Source: Twist Bioscience Corporation